Endoscopic management of bleeding gastric varices with N-butyl, 2-cyanoacrylate glue injection in children with non-cirrhotic portal hypertension
- PMID: 27757413
- PMCID: PMC5066454
- DOI: 10.1055/s-0042-114981
Endoscopic management of bleeding gastric varices with N-butyl, 2-cyanoacrylate glue injection in children with non-cirrhotic portal hypertension
Abstract
Background and study aims: In view of the paucity of literature, we carried out this audit to evaluate the safety and efficacy of N- butyl, 2-cynoacrylate glue injection therapy in secondary prophylaxis of gastric varices in children. Patients and methods: Consecutive children (≤ 18 years) with non-cirrhotic portal hypertension who presented with bleeding from gastric varices and who had undergone cyanoacrylate glue injection therapy were included. They were evaluated for safety, efficacy and complications. Their long-term outcomes and follow-up were recorded. Results: Over 11 years, 28 children with median age 13 (range, 8 to 18) years (68 % boys), underwent cyanoacrylate glue injection for bleeding gastric varices. In 25 (89 %) cases, extrahepatic portal venous obstruction was the etiology and isolated gastric varices were the source of the bleeding. Primary and secondary gastric variceal bleeding was seen in 11 (39 %) and 17 (61 %) children, respectively. A total 36 sessions with median volume of 2 (range, 1 - 5) mL of glue injections were required (2 sessions in 8 children). Hemostasis was achieved in all and 57 % had gastric variceal obliteration. Two children had early (< 1 month) rebleeding and 2 children had late rebleeding. One child had gastric ulcer. Over a median follow-up of 24 (8 - 98) months, 14 children underwent surgery (12 porto-systemic shunt), 2 were lost to follow-up, 1 died and there was no recurrence of bleeding in the remaining 11. Conclusions: Cyanoacrylate glue injection is highly effective mode of secondary prophylaxis of bleeding gastric varices in children with non-cirrhotic portal hypertension. Rebleeding occurred in 14 % but treatment-related complications were uncommon. However, a large controlled clinical trial is required to confirm our findings.
Conflict of interest statement
Figures
References
-
- Bernard O, Alvarez F, Brunelle F. et al.Portal hypertension in children. Clin Gastroenterol. 1985;14:33–55. - PubMed
-
- Yachha S K, Khanduri A, Sharma B C. et al.Gastrointestinal bleeding in children. J Gastroenterol Hepatol. 1996;11:903–907. - PubMed
-
- Poddar U, Thapa B R, Rao K L. et al.Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol. 2008;23:1354–1357. - PubMed
-
- Poddar U, Thapa B R, Sing K. Endoscopic sclerotherapy in children: experience with 257 cases of extrahepatic portal vernous obstruction. Gastrointest Endosc. 2003;57:683–686. - PubMed
-
- Yachha S K, Sharma B C, Kumar M. et al.Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal vein obstruction; a follow up study. J Pediatr Gastroenterol Nutr. 1997;24:49–52. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources